On May 27, 2024, Pangenomic Health Inc., closed the transaction. The company issued 21,502,320 units of the company at a price of CAD 0.05 per unit for the gross proceeds of CAD 1,075,116. The securities issued pursuant to the Offering are subject to a four month plus one day hold period under applicable Canadian securities laws.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 CAD | +33.33% |
|
+33.33% | -50.00% |
05-27 | Pangenomic Health Inc. announced that it has received CAD 1.075116 million in funding | CI |
05-17 | Pangenomic Health Inc. announced that it expects to receive CAD 1 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 2.34M | |
-4.94% | 29.58B | |
+49.49% | 9.98B | |
+34.36% | 4.4B | |
-42.11% | 2.19B | |
-9.44% | 1.6B | |
-28.06% | 1.24B | |
-42.92% | 978M | |
+8.65% | 972M | |
-47.18% | 735M |
- Stock Market
- Equities
- NARA Stock
- News Pangenomic Health Inc.
- Pangenomic Health Inc. announced that it has received CAD 1.075116 million in funding